NasdaqGM:RDNTHealthcare
RadNet (RDNT) Launches Reporting Pro, Is The Stock Still Undervalued?
RadNet (RDNT) is back in focus after its DeepHealth subsidiary commercially launched Reporting Pro, an AI powered radiology tool that combines speech recognition, AI generated findings, and quality checks within a single workflow.
See our latest analysis for RadNet.
Despite a 1-day share price return that declined 1.6% to about US$67.83, RadNet has seen strong short term momentum with a 7-day share price return of 10% and a 30-day share price return of 24.8%. The 1-year total shareholder...